Thomas Johnson

 |  ThomasJohnsonUpdate

Thomas Johnson has recently completed his PhD at the ANZAC Research institute. His thesis focussed on the role of oncoprotein Y-box binding protein in mesothelioma. Since completing his doctorate, he has been working under A/Prof. Andrew Burgess in the Cell Division Laboratory at the ANZAC. He considers himself extremely lucky to have been supported by Sydney Catalyst throughout his PhD with a top-up scholarship and he appreciates the chance to continue his connection with the organisation.